 |
April 28, 2008
|
|
A collaborative assignment with Keio University (Assistant Prof. Masakazu Ueda, Graduate School of Medicine; Prof. Haruma Kawaguchi, Science and Technology) and Tokyo Institute of Technology (Prof. Hiroshi Handa, Bioscience and Biotechnology; Prof. Masanori Abe, Physical Electronics) on diagnosis and treatment system development against breast cancer was adopted as Comprehensive Support Programs by Japan Science and Technology Agent
|
|
January 09, 2008
|
|
Collaboration with CJ Corporation on developing and commercializing Mebiopharm’s anticancer drug MBP-426
Nikkei
Sangyo Shinbun
|
|
December 11, 2007
|
|
Agreement with Korean pharmaceutical company, CJ Corporation, on strategic collaboration
|
|
October 25, 2007
|
|
Presentation on Open Label Phase 1 Study of MBP-426 at the AACR-NCI-EORTC International Conference in San Francisco
|
|
April 25, 2007
|
|
Raised 9th round finance of Yen 357.9Million
|
|
April 18, 2007
|
|
Presentation at
American Association for Cancer Research (AACR) Annual Meeting 2007 in Los Angeles
◆MBP-426◆MBP-Y003
|
|
April 09, 2007
|
|
2nd tumor-targeting product is to enter clinical trial in November
Nikkei
Sangyo Shinbun
|
|
March 28, 2007
|
|
Raised 8th round finance of Yen 600.9Million
|
|
January 24, 2007
|
|
Nanotech DDS drugs - Domestic power matching US companies with new technology
Nikkei
Sangyo Shinbun
|
|
Oct.
27,
2006 |
|
New method of DDS - Domestic power leading cancer treatment
Nikkei
Sangyo Shinbun
|
|
Sep.
28,
2006 |
|
Obtain exclusive sales agreement for Transferrin
Nikkei
Sangyo Shinbun
|
|
Aug.
28,
2006 |
|
Technologies Frontier - targeting to the tumor
Nikkei
Business 2006.8.28 issue
|
|
July
25,
2006 |
|
Hot technologies - Nanotechnology targeting to the tumor
Nikkei
Sangyo Shinbun
|
|
June
29,
2006 |
|
A new formulation targeting to the tumor
Nikkei
Sangyo Shinbun
|
|
May
8,
2006 |
|
Nanotechnologies formulation capsule zeros in on the cancer
Nikkei
Sangyo Shinbun
|
|
April
27,
2006 |
|
Mebiopharm joined an international Bio VB group
Nikkei
Sangyo Shinbun
|
|
April
26,
2006 |
|
Anticancer nanotechnology drug agent begins clinical trial in US
Nikkei
Sangyo Shinbun
|
|
March
27,
2006 |
|
Nanotechnology New Medication
Nikkei
Sangyo Shinbun
|
|
April 26,
2006 |
|
Mebiopharm enters into an exclusive license agreement with NOF Corporation regarding its tumor targeting platform technology
Nikkei Shinbun
|
|
August
9,
2005 |
|
Mebiopharm produces DDS anti-tumor drug in the US and Asia
Nikkan
Kogyo Shinbun
|
|
June 27,
2005 |
|
New drug targeting
affected organ - shown in the
studies
Nikkei
Shinbun
|
|
March
18, 2005 |
|
Early
promise for Mebiopharm's liposomal Oxaliplatin
Scrip ＊ World pharmaceutical
news in U.K.
|
|
February
22, 2005 |
|
Presentation
at AACR - DDS technology for colorectal cancer
Nikkan
Kogyo Shinbun
|
|
February
21, 2005 |
|
Anticancer DDS agent to begin clinical trial in US this autumn
The Chemical Daily
|
|
February
17, 2005 |
|
Presentation
at AACR Pre-clinical study for Transferrin –modified PEG
liposome containing Oxaliplatin
Nikkei
Biotech online
|
|
February
17, 2005 |
|
Presentation
at AACR Pre-clinical study for Transferrin –modified PEG
liposome containing Oxaliplatin In its effort to advance
the adaptation of DDS technology to the development of
anticancer company, we have prepared a presentation
Nikkan
Yakugyo
|
|
February
16, 2005 |
|
Presentation
at AACR “Pre-Clinical Study for Transferrin-modified PEG
liposome containing Oxaliplatin” >>Click
|
|
October 18, 2004 |
|
Manufacturing industry ― competitiveness borne of knowledge
|
|
|
|
Nikkei Sangyo Shimbun |
|
September 13, 2004 |
|
Silicon Valley branch office opened |
|
September 2, 2004 |
|
NHK's
"Ohayo Nippon" program on TV |
|
August
18, 2004 |
|
Carry
out third-party allocation
|
|
|
|
Nikkei
Shinbun |
|
August
10, 2004 |
|
Established U.S.
office to develop new colon cancer drug |
|
|
|
|
|
|
|
◆
Click here to see past articles |
Special
DDS capabilities-Mebiopharm
Top
